FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileiShares Biotechnology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IBB
iShares Biotechnology ETF ETF AnalysisComprehensive ETF analysis for iShares Biotechnology ETF (IBB) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisIBB
IBB
iShares Biotechnology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
IBB
  1. Home
  2. Screener
  3. iShares Biotechnology ETFIBBETF
iShares Biotechnology ETF Logo

iShares Biotechnology ETF

ETF
🇺🇸IBB•NASDAQ•Equity

Your view on IBB

iShares Biotechnology ETF Logo

iShares Biotechnology ETF

ETFIShares
🇺🇸IBB•NASDAQ•Equity
AUM (USD)$11.07B
Expense Ratio0.44%
Yield (TTM)0.17%
Holdings243

Sentiment

—

AUM (USD)

$11.07B

Expense Ratio

0.44%

Yield (TTM)

0.17%

Holdings

243

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

iShares Biotechnology ETF (IBB) is an Equity fund from iShares, listed since 2001, with $11.1B in assets under management, a 0.44% expense ratio and a NAV of $213.68 USD.

Overview for iShares Biotechnology ETF

Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
February 5, 2001
Domicile
US
Website
ishares.com/us/products/239699/ishares-biotechnology-etf
Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
February 5, 2001
Domicile
US
Website
ishares.com/us/products/239699/ishares-biotechnology-etf
Fund Type
ETF
Fund Issuer
IShares
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management
Inception Date
February 5, 2001
Domicile
US
Website
ishares.com/us/products/239699/ishares-biotechnology-etf

About this fund

The iShares Biotechnology ETF seeks to track the investment results of an index composed of U.S.-listed equities in the biotechnology sector.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.44%

Yield (TTM)

0.17%

AUM

$11.07B

Fund Details

NAV$213.68 USD
Holdings243
Average Volume1.68M
Inception DateFebruary 5, 2001
Asset ClassEquity
Fund IssuerIShares
DomicileUS
ISINUS4642875565
CUSIP464287556
NAV CurrencyUSD

Expense Ratio

0.44%

Dividend Yield (TTM)

0.17%

Assets Under Management

$11.07B

NAV

$213.68 USD

Holdings

243

Average Volume

1.68M

Inception Date

February 5, 2001

Asset Class

Equity

Fund Issuer

IShares

Domicile

US

ISIN

US4642875565

CUSIP

464287556

NAV Currency

USD

Expense Ratio

0.44%

Dividend Yield (TTM)

0.17%

Assets Under Management

$11.07B

NAV

$213.68 USD

Holdings

243

Average Volume

1.68M

Inception Date

February 5, 2001

Asset Class

Equity

Fund Issuer

IShares

Domicile

US

ISIN

US4642875565

CUSIP

464287556

NAV Currency

USD

Distributions · last 12 months

Quarterly · 4 payments

Ex-datePaidAmount
Sep 15, 2026Sep 18, 2026$0.0112
Jun 15, 2026Jun 18, 2026$0.0238
Mar 17, 2026Mar 20, 2026$0.1218
Dec 16, 2025Dec 19, 2025$0.1831
Total, 12 months$0.34 a share

Dividend yield (TTM) 0.17% = $0.34 paid per share in the 12 months to Nov 20, 2026 ÷ the $205.39 price. Past distributions; future payments can differ.

Data last updated: Nov 9, 2026, 08:10 AM

Sectors

How the fund's assets are split across sectors.

1 sectors
  • 1Healthcare
    100.0%

Top sector

Healthcare

Top weight

100.0%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

246 positions
1GILDGILEAD SCIENCES
9.37%
2AMGNAMGEN INC
8.38%
3VRTXVERTEX PHARMACEUTICALS
8.00%
4REGNREGENERON PHARMACEUTICALS
6.73%
5MRNAMODERNA
5.16%
6ARGXARGENX SE ADR
3.76%
7NTRANATERA
2.80%
8BIIBBIOGEN
2.65%
9ONCBEONE MEDICINES AG
2.44%
10ILMNILLUMINA INC
2.27%
11RVMDREVOLUTION MEDICINES
2.21%
12GMABGENMAB SPONSORED ADR
2.03%
13INSMINSMED
1.85%
14UTHRUNITED THERAPEUTICS
1.72%
15INCYINCYTE CORP
1.70%

Concentration

Total Holdings246
Top 10 Weight51.57%
Top HoldingGILD
Top Weight9.37%
1GILDGILEAD SCIENCES
9.37%
2AMGNAMGEN INC
8.38%
3VRTXVERTEX PHARMACEUTICALS
8.00%
4REGNREGENERON PHARMACEUTICALS
6.73%
5MRNAMODERNA
5.16%
6ARGXARGENX SE ADR
3.76%
7NTRANATERA
2.80%
8BIIBBIOGEN
2.65%
9ONCBEONE MEDICINES AG
2.44%
10ILMNILLUMINA INC
2.27%
11RVMDREVOLUTION MEDICINES
2.21%
12GMABGENMAB SPONSORED ADR
2.03%
13INSMINSMED
1.85%
14UTHRUNITED THERAPEUTICS
1.72%
15INCYINCYTE CORP
1.70%

Total Holdings

246

Top 10 Weight

51.57%

Top Holding

GILD

Top Weight

9.37%

1GILDGILEAD SCIENCES
9.37%$1.02B
2AMGNAMGEN INC
8.38%$912.62M
3VRTXVERTEX PHARMACEUTICALS
8.00%$870.72M
4REGNREGENERON PHARMACEUTICALS
6.73%$732.90M
5MRNAMODERNA
5.16%$562.22M
6ARGXARGENX SE ADR
3.76%$409.01M
7NTRANATERA
2.80%$304.83M
8BIIBBIOGEN
2.65%$288.35M
9ONCBEONE MEDICINES AG
2.44%$265.50M
10ILMNILLUMINA INC
2.27%$247.35M
11RVMDREVOLUTION MEDICINES
2.21%$240.95M
12GMABGENMAB SPONSORED ADR
2.03%$220.80M
13INSMINSMED
1.85%$201.55M
14UTHRUNITED THERAPEUTICS
1.72%$187.19M
15INCYINCYTE CORP
1.70%$185.06M

Total Holdings

246

Top 10 Weight

51.57%

Top Holding

GILD

Top Weight

9.37%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
IBBiShares Biotechnology ETFThis fundEquity0.44%$11.1B243

Comparable funds

  • DLNWisdomTree U.S. LargeCap Dividend FundUS Equity0.28%$6.4B305
  • EWTiShares MSCI Taiwan ETFEquity0.59%$9.4B76
  • IDViShares International Select Dividend ETFEquity0.50%$8.4B100
  • IJJiShares SP Mid-Cap 400 Value ETFEquity0.18%$8.6B303
  • IJSiShares SP Small-Cap 600 Value ETFEquity0.18%$7.5B495
  • IJTiShares SP Small-Cap 600 Growth ETFEquity0.18%$7.3B369
  • IOOiShares Global 100 ETFEquity0.40%$8.9B102
  • IXNiShares Global Tech ETFEquity0.37%$8.0B131

More IShares ETFs

  • UAEiShares MSCI UAE ETFEquity0.59%$323M58
  • URTHiShares MSCI World ETFEquity0.24%$9.6B1,249
  • USCLiShares Climate Conscious Transition MSCI USA ETFEquity0.08%$2.6B390
  • USHYiShares Broad USD High Yield Corporate Bond ETFFixed Income0.08%$27.3B1,896
  • USIGiShares Broad USD Investment Grade Corporate Bond ETFFixed Income0.04%$18.0B11,631
  • USMViShares MSCI USA Min Vol Factor ETFEquity0.15%$23.8B174
  • USRTiShares Core US REIT ETFReal Estate (Listed/REITs)0.08%$4.2B122
  • IYZiShares U.S. Telecommunications ETFEquity0.37%$661M22
  • IZZ.AXiShares China Large-Cap ETFEquity0.60%$454M50
  • JPXNiShares JPX-Nikkei 400 ETFEquity0.48%$135M398
  • JXIiShares Global Utilities ETFEquity0.37%$353M65
  • KSAiShares MSCI Saudi Arabia ETFEquity0.75%$557M109
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News